Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00735254 · ClinicalTrials.gov registry record · NA
Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT00735254: Clinical Trial NA study, sponsored by The Cleveland Clinic.
NCT00735254 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00735254, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of using a pulsed dye laser (the VBEAM), a non-ablative laser (the Affirm) and a combination of both lasers to improve the appearance of your surgical scar. Both the pulsed dye laser and Affirm laser are approved by the US Food and Drug Administration (FDA) for the treatment of scars. Surgical scars are a type of scar that can benefit from laser therapy. Redness and the appearance of small blood vessels near the surface of the skin (telangiectasias) develop in such scars as part of the normal healing process and usually spontaneously remit, but often slowly and incompletely. In many cases, lasers can accelerate the clearing of this redness and also improve scar texture.
Primary Outcome
The purpose of this study is to determine the efficacy of the 585-nm pulsed dye laser (PDL) and 1440-nm Affirm laser in the treatment of surgical scars starting one week after closure of transverse abdominal incision.
Interventions
- OTHER Placebo
- DEVICE pulsed dye laser
- DEVICE Affirm Laser
- DEVICE combined PDL and Affirm Lasers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-01 |
| Phase | NA |
Why NCT00735254 stopped before completion
NCT00735254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00735254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00735254 about?
NCT00735254 is a clinical study titled "Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars". The purpose of this study is to examine the effect of using a pulsed dye laser (the VBEAM), a non-ablative laser (the Affirm) and a combination of both lasers to improve the appearance of your surgical scar. Both the pulsed dye laser and Affirm laser are approved by the US Food and Drug Administrati...
What is the current status of trial NCT00735254?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2008-07. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00735254?
The interventions under investigation include: Placebo (OTHER), pulsed dye laser (DEVICE), Affirm Laser (DEVICE), combined PDL and Affirm Lasers (DEVICE).
Who is sponsoring clinical trial NCT00735254?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00735254's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia